EP2162527A1 - Verfahren zur fermentation von zellkulturen - Google Patents
Verfahren zur fermentation von zellkulturenInfo
- Publication number
- EP2162527A1 EP2162527A1 EP08760919A EP08760919A EP2162527A1 EP 2162527 A1 EP2162527 A1 EP 2162527A1 EP 08760919 A EP08760919 A EP 08760919A EP 08760919 A EP08760919 A EP 08760919A EP 2162527 A1 EP2162527 A1 EP 2162527A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- metabolic
- determined
- cell
- target
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 65
- 238000004113 cell culture Methods 0.000 title claims abstract description 21
- 230000002503 metabolic effect Effects 0.000 claims abstract description 30
- 230000008569 process Effects 0.000 claims abstract description 26
- 230000033228 biological regulation Effects 0.000 claims abstract description 8
- 238000004364 calculation method Methods 0.000 claims abstract description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 44
- 238000000855 fermentation Methods 0.000 claims description 28
- 230000004151 fermentation Effects 0.000 claims description 28
- 235000015097 nutrients Nutrition 0.000 claims description 27
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 23
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 17
- 230000015572 biosynthetic process Effects 0.000 claims description 17
- 229910052760 oxygen Inorganic materials 0.000 claims description 17
- 239000001301 oxygen Substances 0.000 claims description 17
- 239000001963 growth medium Substances 0.000 claims description 16
- 239000001569 carbon dioxide Substances 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 239000007789 gas Substances 0.000 claims description 13
- 230000001105 regulatory effect Effects 0.000 claims description 12
- 238000004868 gas analysis Methods 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 230000036284 oxygen consumption Effects 0.000 claims description 6
- 238000009530 blood pressure measurement Methods 0.000 claims description 4
- 238000002474 experimental method Methods 0.000 claims description 3
- 230000037353 metabolic pathway Effects 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 2
- 238000011065 in-situ storage Methods 0.000 claims description 2
- 230000000241 respiratory effect Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 45
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 20
- 239000000047 product Substances 0.000 description 20
- 239000000758 substrate Substances 0.000 description 20
- 238000005259 measurement Methods 0.000 description 16
- 230000004060 metabolic process Effects 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 210000004408 hybridoma Anatomy 0.000 description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 8
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 8
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 238000004886 process control Methods 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 238000010923 batch production Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229960000074 biopharmaceutical Drugs 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 210000004962 mammalian cell Anatomy 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000004102 animal cell Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 238000012625 in-situ measurement Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 229940127024 acid based drug Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 238000012365 batch cultivation Methods 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000006706 cellular oxygen consumption Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 235000020938 metabolic status Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/26—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pH
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
- C12M41/32—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of substances in solution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
- C12M41/34—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of gas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/48—Automatic or computerized control
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Definitions
- the invention relates to a method and / or a device for an RQ-regulated feed process in cell cultures.
- Biopharmaceutical drugs are rapidly gaining in importance.
- Biopharmaceuticals are understood to be (recombinant) therapeutic proteins obtained by genetic engineering methods, monoclonal antibodies or nucleic acid-based drugs.
- the volume of biopharmaceuticals produced by cell cultures has more than doubled.
- the development has reached such a dynamic that the cell culture fermentation capacities worldwide become the limiting factor.
- the optimization of these large-scale production processes is therefore becoming increasingly important.
- the challenge will be to cost-effectively produce the corresponding products in competition.
- fed-batch fermentation is currently the most widely used process control strategy.
- other process parameters such as: As the pH, kept constant. The acidified by metabolic end product is thus neutralized and allows the culture to grow unhindered. The culture time can be extended by the fed-batch method to up to two weeks and increase the product titre in some cases up to 10-fold.
- the maintenance of constant culture parameters is of particular importance for cell cultures. Not optimal culture parameters not only lower the productivity of the cells.
- the aerobic degradation of nutrients leads to a decrease in the concentration of the substrate to be metabolized and to a depletion of oxygen (respiratory chain).
- the latter can be determined by accounting for the exhaust air as the Oxygen Transfer Rate (OTR) and is a measure of the current oxygen consumption of the cell.
- OTR Oxygen Transfer Rate
- the direct relationship between substrate and oxygen consumption rates has been demonstrated by several groups of work (T. Anderlei, Online Respiration Activity Measurement (OTR, CTR, RQ) in shake flasks, Biochemical Engineering, 2004, 17, 187-194, Q. Feng, On -Im monitoring of oxygen uptake rate and its application in hybridoma culture, Sheng Wu Gong Cheng Xue Bao., 2003, 19 (5), 593-607; M. Canzoneri, Respiratory activity of mammalian cells, BioForum, 2006, 2).
- the feed process or the fed-batch strategy is used as standard in various production processes (recombinant proteins, baker's yeast, antibiotics, etc.) in industry.
- the limiting substrates are supplied after the deceleration phase.
- the substrate is supplied to the extent that it is metabolized (quasi steady state), d. H. with the adjusted substrate concentration, a certain growth rate can be set (monodic kinetics).
- Essential for the fed-batch technique are the instructions for the specific culture / production processes. They are based on intensive research into the course of culture and the derivation of corresponding, specific procedures / instructions.
- a major disadvantage of conventional process control is the offline determination of the substrate consumption rates, substrate concentrations and the current cell density. As a rule, samples must be taken at regular intervals in the running process and then analyzed with external devices or with rapid tests. Based on these results, the feed rate is recalculated and then the feed rate is adjusted. The lack of online measurement of substrate concentrations makes control of the process expensive and difficult. Variations in product yield and quality are possible consequences of this type of process control.
- the time interval between the offline analysis of the samples and the adjustment of the new process values can lead to incorrect settings of the inflow rate and thus to an unwanted nutrient limitation.
- the aerobic metabolism of the substrates consumes oxygen and produces carbon dioxide.
- the ratio of the amount of CO 2 released in a certain period of time to the amount of O 2 taken up in the same time unit is defined as the respiratory quotient (RQ).
- RQ respiratory quotient
- the measured CTR is a sum signal of cell-specific and buffer-induced carbon dioxide formation. The latter results from the effect of the buffer in acidification of the cells. In this case, the acidification causes additional CO2 to be generated chemically.
- the determined RQ values lead to inflated values because only a part of the CO2 was produced by the metabolism of the cells and do not represent the metabolic RQ of the cells. Since the term RQ is misleading here, the term TQ (Transfer Quotient) was introduced. This represents the ratio of the total CO 2 formation to the total O 2 consumption.
- the measured TQ does not say anything about the metabolic RQ and thus does not give any indication of the metabolic activity of the cell.
- CER cell-specific carbon dioxide formation rate
- Object of the present invention is to provide a method and a corresponding device for RQ-regulated supply of culture medium and / or nutrients available, which overcomes the described problems of the prior art. It is to be achieved according to the invention by determining the metabolic RQ value that the supply of culture medium and / or nutrients to a sensitive on-line control is made accessible by means of online control. At the same time an effective increase in productivity in cell culture processes should be achieved. This was not possible with the previous methods of fermentation technology. Because the methods known from culturing with microorganisms can not be transferred to the much more sensitive cell cultures. This is especially true when using animal cell cultures.
- This object is achieved by a method for the fermentation of cell cultures in which
- the metabolic RQ is determined online, - the metabolic RQ serves as an actual value for a regulation, - the target RQ for the desired productivity or product characteristic is determined as a setpoint for a control, and
- the supply of culture medium and / or nutrients is regulated so that sets an optimal cell or product yield and / or a desired product quality or product property.
- the process according to the invention can be carried out for the production of proteins, for example pharmaceutical proteins.
- the process can be carried out with animal or plant cells. Both continuous cell lines and genetically engineered cells can be used in the method.
- the target RQ can be determined in a preliminary test (eg batch operation, continuous operation or chemostat operation, continuous operation corresponds to continuous process control) or in the ongoing process. Furthermore, the target RQ can be calculated from the stoichiometry of the metabolic pathway. Online, the metabolic RQ is determined by the appropriate combination of gas analysis values and in situ measurements such as pH and temperature. The gas analysis is carried out by means of partial pressure measurement, mass and volume flow determination or any combination of two or more of said parameters.
- the measurement of the metabolic RQ value is based on the measurement and calculation methods described in the prior art.
- a use of the RQ value to control a fermentation of cell cultures has not yet been shown.
- the present invention shows for the first time that it is possible in a method for fermentation of cell cultures from the measured RQ course reproducibly to close various metabolic states and that set during the fermentation various discrete RQ conditions based on the cell-specific productivity.
- the optimal RQ value can be determined by recording a complete RQ progression of continuous cell lines and identifying and biochemically interpreting the individual RQ phases.
- the target RQ in the course of an upstream fermentation, calculated from the stoichiometry of the metabolic pathway, but also in the ongoing process can be determined.
- the online control and regulation of the desired RQ value thus enables an exact supply of the required culture medium and / or nutrients to achieve either a high cell yield, a high product yield, a certain product quality or product property.
- Saccharomyces cerevisiae can produce alcohol under anaerobic conditions.
- Crabtree effect refers to and describes aerobic alcohol formation above a critical glucose concentration of 100 mg / l, whereas below 100 mg / l, biomass production preferably proceeds.
- the measured RQ is well over one in ethanol production. In contrast, complete oxidation of the sugar to CO2 and water has an RQ of one.
- the process control according to the invention is completely independent of substrate offline measurements and is preferably based on the measurement of the gas exchange. Due to the exact adherence to a specific substrate concentration, the yield of biomass or ethanol can be increased many times over.
- the respiration quotient is preferably measured by determining the appropriate combination of the gas analysis values and the measurements made in situ.
- the gas analysis can be carried out by means of all methods available to the person skilled in the art.
- the prerequisite is that the methods are suitable for online determination.
- Examples of gas analysis are partial pressure measurements as well as the determination of the mass and volume flow.
- the in situ measurement can also be measured by the usual methods known to those skilled in the art.
- the carbon dioxide content preferably the carbon dioxide content
- Oxygen content, the pH and the temperature determined. O 2 and CO 2 content can, for. B. be determined by means of partial pressure measurement. Possibly. can also more
- Oxygen content and the pH, for example, conventional electrodes are considered.
- the determination of the desired value can, according to the invention, preferably be carried out before the start of production. However, the setpoint determination can also take place at any other time points and, depending on the requirements of the operation, also be repeated as often as desired. It can be done in a separate fermenter or in the production fermenter. Preferably, the measurement is in batch mode in a separate vessel.
- the method according to the invention can be used for plant or animal cells.
- continuous cell lines or genetically modified cells can also be used.
- the process according to the invention is particularly preferred for the use of animal cell cultures.
- a particularly preferred range is the production of proteins, in particular of pharmaceutically applicable proteins.
- the process according to the invention can be carried out in the fermenters which are known from the prior art and are suitable for preferably submersed processes. Accordingly, for example bubble columns, injector operated systems, loop reactors and stirred reactors in the form of single and multi-stage systems come into consideration. Particularly preferred are stirred reactors.
- the reactors are regularly equipped with the state-of-the-art measuring, control and regulating systems. These include devices for online and offline measurement. Examples include pH, pÜ2-pCÜ2 measuring devices, in particular the use of appropriate sensors. Likewise, z. As the use of measurements of the supply and removal of substrate and the supply and exhaust according to the invention advantageous.
- a device which is suitable for carrying out the method described enables the online determination of the metabolic RQ with the aid of the supply and exhaust air, as well as the pH value and the temperature.
- the control of media and nutrient supply is automatic based on the RQ.
- dosing devices gaseous, liquid or solid media
- a regulation of the oxygen or. NaOH / CO 2 supply to maintain a desired oxygen concentration or pH in the fermenter are performed.
- the apparatus for carrying out the method may include a) a fermenter; b) a gas mixing system; c) supply air ducts for gas; d) exhaust ducts; e) measuring devices for determining the oxygen and CO 2 concentration and the mass flow in the supply air and in the exhaust air for determining the oxygen consumption rate OTR and the carbon dioxide formation rate CTR; f) device for measuring the pH and the temperature; g) Apparatus for determining CER and metabolic RQ from the temperature, pH, oxygen concentration and carbon dioxide concentration values; h) contain an RQ regulator for RQ-based control of the supply of culture medium and / or nutrients.
- P1 corresponds to phase 1; P2 of phase 2; Phase 3 P3; Phase 4 P4; Phase 5 P5 and Phase 6 P6.
- FIG. 1 Course of the RQ in a batch fermentation of the hybridoma cell line CF-10H5. Continuous line: glutamine; dashed line: glucose; continuous line in gray: RQ.
- Fig. 2 Course of the cell-specific productivity. Dashed line: cell-specific productivity; continuous line in gray: RQ.
- FIG. 4 Dependence of the RQ on the glutamine concentration in the chemostatic mode of operation. Continuous line: glutamine; continuous line in gray: RQ.
- Fig. 5 Glutamine course in the RQ-regulated fed-batch (nominal value RQ 0.66). Continuous line: glutamine; continuous line in gray: RQ. The arrow marks the start of the RQ-controlled Fed-Batch process.
- Fig. 6 Productivity course in the RQ-regulated Fed-Batch. Dashed line: cell-specific productivity; continuous line in gray: RQ.
- FIG. 7 Process flow diagram of the RQ-controlled fed-batch process.
- FIG. 1 fermenter; 2: stirrer; 3: supply air; 4: exhaust air; 5 and 22: pH and p ⁇ 2 electrodes; 7: device for the exhaust gas analysis; 8: device for determining the metabolic RQ; 9: nutrient container; 10: nutrient pump; 11: supply line.
- FIG. 8 shows an apparatus for carrying out the RQ-controlled fed-batch process.
- 1 fermenter; 2: stirrer; 3: supply air for gas; 4: exhaust ducts; 5: pH electrode; 6-7: Measuring devices for determining the oxygen and CO 2 concentration and the mass flow in the incoming air; 8: device for determining the metabolic RQ; 9: nutrient container; 10: nutrient pump; 11: supply line; 12: device for measuring the pH value; 13: device for measuring the temperature; 14-15: measuring devices for determining the oxygen and CO 2 concentration and the mass flow in the exhaust air; 16: Device for determining the oxygen consumption rate OTR; 17: device for determining the carbon dioxide formation rate CTR; 18: device for determining the CER; 19: predetermined target RQ; 20: RQ controller; 21: gas mixing system;
- FIG. 1 shows the course of the RQ in a batch fermentation of the hybridoma cell line CF-10H5.
- FIG. 1 shows the RQ curve and the decrease in the glucose and glutamine concentration during the batch cultivation of the hybridoma cell line CF-10H5 in the fermenter.
- the glutamine concentration decreases continuously over the course of the culture until it is completely exhausted after about 60 hours.
- Glucose concentration decreases throughout the culture but never limits culture until the end of fermentation.
- various discrete RQ states (phases 1 to 6) occur during the fermentation.
- FIG. 2 shows the course of the cell-specific productivity in the batch.
- FIG. 4 shows the dependence of the RQ on the glutamine concentration in the chemostatic mode of operation.
- This type of process control reflects the continuous operation of a fermentation without cell retention.
- This system is characterized by the continuous feed of fresh culture medium and the effluent of spent culture medium including cells.
- the flow equilibrium taking into account the flow rate (D ⁇ ma ⁇ ) allows the setting of defined growth rates, substrate, product and cell concentrations in the fermenter.
- FIG. 5 shows the glutamine profile in the RQ-regulated fed-batch (nominal value RQ 0.66).
- FIG. 6 shows the productivity profile in the RQ-regulated fed batch (nominal value RQ 0.66).
- the RQ is regulated by the controlled addition of culture medium and / or nutrients (here: fed-batch medium, quadruple-concentrate of nutrients).
- Factor four be increased. From an initial productivity of approximately 1 E-7 ⁇ g / N / h, productivity was increased to approximately 4E-7 ⁇ g / N / h.
- FIG. 7 shows a process flow diagram with an example of the application of the RQ control according to the invention.
- the production takes place in a fermenter 1 with a stirrer 2.
- the fermenter is equipped with a supply air 3 and an exhaust air 4.
- the electrodes 5 and 22 are provided for the measurement of the pH and the pÜ2.
- the exhaust 4 a device for the exhaust gas analysis 7 is still arranged.
- the RQ can be determined as a function of the OTR, CTR, pH and the temperature.
- the regulation of the inflow of culture media and / or nutrients 9 then takes place.
- the RQ regulator actuates the valve of the nutrient pump 10 for the supply line 11. 7.
- FIG. 8 shows a process flow diagram of the device for carrying out the method.
- the gas composition and the gas flow is determined.
- the composite through the gas mixing system 21 supply air 3 is first passed through the device to determine the oxygen and carbon dioxide content 6-7 of the supply air.
- OTR oxygen consumption rate
- the measurement pH 5 and the temperature 13 in the fermenter in combination with the calculation of the CTR allows the determination of the CER 18 and thus of the metabolic RQ 8.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Sustainable Development (AREA)
- Computer Hardware Design (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007028355 | 2007-06-15 | ||
| PCT/EP2008/057378 WO2009013066A1 (de) | 2007-06-15 | 2008-06-12 | Verfahren zur fermentation von zellkulturen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2162527A1 true EP2162527A1 (de) | 2010-03-17 |
Family
ID=40044101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP08760919A Withdrawn EP2162527A1 (de) | 2007-06-15 | 2008-06-12 | Verfahren zur fermentation von zellkulturen |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP2162527A1 (de) |
| WO (1) | WO2009013066A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014151645A1 (en) * | 2013-03-15 | 2014-09-25 | Butamax Advanced Biofuels Llc | Process for maximizing biomass growth and butanol yield by feedback control |
| US20160024204A1 (en) | 2013-03-15 | 2016-01-28 | Bristol-Myers Squibb Company | Methods for producing antibodies |
| CN103869091A (zh) * | 2014-03-28 | 2014-06-18 | 南京工业大学 | 一种在线检测生物发酵尾气中氧气和二氧化碳的装置及方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH078231B2 (ja) * | 1985-03-25 | 1995-02-01 | 株式会社日立製作所 | 培養制御方法及び培養制御装置 |
-
2008
- 2008-06-12 EP EP08760919A patent/EP2162527A1/de not_active Withdrawn
- 2008-06-12 WO PCT/EP2008/057378 patent/WO2009013066A1/de not_active Ceased
Non-Patent Citations (3)
| Title |
|---|
| BJÖRN FRAHM ET AL: "Determination of dissolved CO2 concentration and CO2 production rate of mammalian cell suspension culture based on off-gas measurement", JOURNAL OF BIOTECHNOLOGY, vol. 99, no. 2, 1 October 2002 (2002-10-01), pages 133 - 148, XP055013633, ISSN: 0168-1656, DOI: 10.1016/S0168-1656(02)00180-3 * |
| HENDRIK P. J. BONARIUS ET AL: "Determination of the respiration quotient in mammalian cell culture in bicarbonate buffered media", BIOTECHNOLOGY AND BIOENGINEERING, vol. 45, no. 6, 20 March 1995 (1995-03-20), pages 524 - 535, XP055013632, ISSN: 0006-3592, DOI: 10.1002/bit.260450610 * |
| See also references of WO2009013066A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009013066A1 (de) | 2009-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3535050C2 (de) | ||
| DE69722391T2 (de) | Gärungs-steuerungssysteme | |
| DE2938339C3 (de) | ||
| EP0487867A1 (de) | Verfahren zur Erzeugung von Zellmasse und/oder Fermentierungsprodukten unter sterilen Bedingungen sowie Vorrichtung zur Durchführung des Verfahrens | |
| DE3688534T2 (de) | Verfahren und Gerät zur Kultivierungssteuerung. | |
| EP3385366A1 (de) | Verfahren zur kontrolle eines biotechnologischen prozesses | |
| DE69010529T2 (de) | Verfahren und Vorrichtung zur Steuerung der Kultivierungsbedingungen von tierischen Zellen. | |
| WO2009013066A1 (de) | Verfahren zur fermentation von zellkulturen | |
| DE3871573T2 (de) | Verfahren zur zuechtung durch kontrollieren der acetatkonzentration und apparat dafuer. | |
| EP3948875A2 (de) | Verfahren zur gesteuerten hefeproduktion | |
| CN118996018A (zh) | 一种生物发酵控制系统 | |
| DE19520485A1 (de) | Bioreaktor | |
| Peissker et al. | Model aided dynamic process analysis and optimization | |
| DE4001518C2 (de) | ||
| EP3688133B1 (de) | Optimierung von fermentationsprozessen | |
| DE69113168T2 (de) | Verfahren zur automatischen Steuerung der Traubenmostgärung. | |
| DE60107653T2 (de) | Verfahren zur Steuerung der Züchtung von Bräuhefe in einem Nährmedium | |
| WO2025224276A1 (de) | Verfahren und vorrichtung zum erzeugen von biogas | |
| WO2003029444A2 (de) | Verfahren und vorrichtung zur gewinnung von sekundären pflanzeninhaltsstoffen | |
| DD210300A1 (de) | Verfahren zur steuerung von prozessen der biotechnischen stoffwandlung | |
| EP0758398B1 (de) | Verfahren zur biotransformation von carbonsäuren in gegenwart eines mikroorganismus | |
| DD225438A1 (de) | Verfahren zur kontinuierlichen zuechtung von backhefe | |
| DE2649547A1 (de) | Verfahren zur kontinuierlichen herstellung mikrobieller biomasse und vorrichtung zur durchfuehrung dieses verfahrens | |
| DD149873A3 (de) | Verfahren zur steuerung des kultivierungsprozesses von mikroorganismen | |
| DE2241258A1 (de) | Kontinuierliches verfahren zur umwandlung von methan in eiweisstoffe durch kultivierung von methan verwertenden mikroorganismen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20091126 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: FISCHER, RAINER Inventor name: BISELLI, MANFRED Inventor name: KRUEGER, ROLF Inventor name: CANZONERI, MICHELANGELO Inventor name: ZANG, WERNER |
|
| 17Q | First examination report despatched |
Effective date: 20100512 |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20120501 |